1. Home
  2. Labeler Index
  3. Twi Pharmaceuticals, Inc.
  4. 24979-710
  5. NDC Package Code: 24979-710-51 Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound)

NDC Package 24979-710-51 Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound)

Paclitaxel Injection, Powder, Lyophilized, For Suspension Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
24979-710-51
Package Description:
1 VIAL, SINGLE-USE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-USE
Product Code:
24979-710
Proprietary Name:
Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound)
Non-Proprietary Name:
Paclitaxel
Substance Name:
Paclitaxel
Usage Information:
Paclitaxel is used to treat various types of cancer. It is a cancer chemotherapy drug that works by slowing or stopping cancer cell growth.
11-Digit NDC Billing Format:
24979071051
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 583214 - PACLitaxel 100 MG Injection
  • RxCUI: 583214 - paclitaxel 100 MG Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Twi Pharmaceuticals, Inc.
    Dosage Form:
    Injection, Powder, Lyophilized, For Suspension - A liquid preparation, intended for parenteral use that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • PACLITAXEL 100 mg/20mL
    • Pharmacologic Class(es):
  • Microtubule Inhibition - [PE] (Physiologic Effect)
  • Microtubule Inhibitor - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    NDA021660
    Marketing Category:
    NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
    Start Marketing Date:
    04-01-2022
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 24979-710-51 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    24979071051J9264Paclitaxel protein bound1 MG11100100

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 24979-710-51?

    The NDC Packaged Code 24979-710-51 is assigned to a package of 1 vial, single-use in 1 carton / 20 ml in 1 vial, single-use of Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound), a human prescription drug labeled by Twi Pharmaceuticals, Inc.. The product's dosage form is injection, powder, lyophilized, for suspension and is administered via intravenous form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 24979-710 included in the NDC Directory?

    Yes, Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound) with product code 24979-710 is active and included in the NDC Directory. The product was first marketed by Twi Pharmaceuticals, Inc. on April 01, 2022 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 24979-710-51?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 24979-710-51?

    The 11-digit format is 24979071051. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-224979-710-515-4-224979-0710-51